Twin - the issue with the absence of POC1 in the qrtly is- is this another case of BBI? I.e.- 'Somebody that we used to know?'
Discussed endlessly in previous qrtlys by ado then nothing but "pleasing progress"??
What's galling about this is; what's next on the spruiking line- IMRA?
I am extremely relieved that we are acquiring Diasorin and will go it somewhat alone (or are at least be the masters of our own destiny). I have a nest egg put aside for hopefully a discounted capital raise however it comes. I had thought poc would be in there somewhere but that along with batteries is a pipe dream. Diasorin at least is a tangible
Money generating asset that is an earner.
Ps: P Off about the typo in the email address for contacting Jane Lowe at the end of the quarterly - stupid mistake...
ADO Price at posting:
8.8¢ Sentiment: Hold Disclosure: Held
